Timothy Caulfield | Academic Influence

Timothy Caulfield's AcademicInfluence.com Rankings

Timothy Caulfield

Law

#1540

World Rank

#1932

Historical Rank

Common Law

#116

World Rank

#125

Historical Rank

International Law

#723

World Rank

#886

Historical Rank

Download Badge

Law

Why Is Timothy Caulfield Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Timothy Allen Caulfield is a Canadian professor of law at the University of Alberta, the research director of its Health Law Institute, and current Canada Research Chair in Health Law and Policy. He specializes in legal, policy and ethical issues in medical research and its commercialization. In addition to professional publications, he is the author of several books aimed at the general reader and host of a television documentary series debunking pseudoscientific myths. He is a fellow of the Committee for Skeptical Inquiry and the Pierre Elliott Trudeau Foundation.

(See a Problem?)

Timothy Caulfield's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Science communication reconsidered (2009) (363)
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. (2008) (299)
Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers (2004) (292)
Research Ethics Recommendations for Whole-Genome Research: Consensus Statement (2008) (254)
Research ethics and the challenge of whole-genome sequencing (2008) (213)
Deflating the Genomic Bubble (2011) (185)
Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. (1998) (181)
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines (2016) (174)
Ethics and Genomic Incidental Findings (2013) (156)
DNA databanks and consent: A suggested policy option involving an authorization model (2003) (155)
Marketing of unproven stem cell–based interventions: A call to action (2017) (142)
Evidence and anecdotes: an analysis of human gene patenting controversies (2006) (125)
Race and ancestry in biomedical research: exploring the challenges (2009) (118)
Direct-to-consumer genetic testing: perceptions, problems, and policy responses. (2012) (109)
Confronting stem cell hype (2016) (104)
Science and the Sources of Hype (2012) (104)
Biotechnology and the popular press: hype and the selling of science. (2004) (96)
Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales (2007) (93)
Direct‐to‐consumer genetic testing: good, bad or benign? (2010) (90)
Biobanks, consent and claims of consensus (2012) (90)
Broad Consent in Biobanking: Reflections on Seemingly Insurmountable Dilemmas (2009) (89)
Personal medicine—the new banking crisis (2012) (85)
A review of the key issues associated with the commercialization of biobanks (2014) (84)
Economic Consequences Incurred by Living Kidney Donors: A Canadian Multi-Center Prospective Study (2014) (82)
Stem cell hype: Media portrayal of therapy translation (2015) (78)
Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? (2013) (74)
Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate (2013) (73)
Genes, cells, and biobanks: Yes, there’s still a consent problem (2017) (69)
Angelina Jolie’s faulty gene: newspaper coverage of a celebrity’s preventive bilateral mastectomy in Canada, the United States, and the United Kingdom (2013) (68)
Canadian health law and policy (2002) (68)
Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries (2010) (67)
Stem Cell Tourism and Doctors' Duties to Minors—A View From Canada (2010) (67)
iPS Cells: Mapping the Policy Issues (2009) (66)
Pseudoscience and COVID-19 — we’ve had enough already (2020) (64)
Role and reality: technology transfer at Canadian universities. (2010) (62)
Human dignity: a guide to policy making in the biotechnology era? (2006) (62)
The Future of Personal Genomics (2007) (61)
Stem cell clinics in the news (2010) (60)
Myriad and the mass media: the covering of a gene patent controversy (2007) (59)
Open science versus commercialization: a modern research conflict? (2012) (59)
Patenting human genetic material: refocusing the debate (2000) (59)
Restricting marketing to children: Consensus on policy interventions to address obesity (2013) (58)
New ISSCR guidelines: clinical translation of stem cell research (2016) (56)
Regulating Direct-to-Consumer Personal Genome Testing (2010) (52)
Emerging Ethical, Legal and Social Issues Associated with Stem Cell Research & and the Current Role of the Moral Status of the Embryo (2009) (50)
The commercialization of university-based research: Balancing risks and benefits (2015) (50)
The Commercialisation of Medical and Scientific Reporting (2004) (48)
Celebrities’ impact on health-related knowledge, attitudes, behaviors, and status outcomes: protocol for a systematic review, meta-analysis, and meta-regression analysis (2017) (48)
Underwhelmed: hyperbole, regulatory policy, and the genetic revolution. (2000) (48)
Cancer patient perceptions on the ethical and legal issues related to biobanking (2013) (46)
Policy: Global standards for stem-cell research (2016) (46)
Implicit hype? Representations of platelet rich plasma in the news media (2017) (45)
Trust, patents and public perceptions: the governance of controversial biotechnology research (2006) (44)
Popular Media, Biotechnology and the ‘Cycle of Hype (2005) (44)
Biobanking, consent, and control: a survey of Albertans on key research ethics issues. (2012) (44)
A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals (2005) (43)
Scientists’ perspectives on consent in the context of biobanking research (2014) (43)
Attitudes toward strategies to increase organ donation: views of the general public and health professionals. (2012) (43)
The Stem Cell Research Environment: A Patchwork of Patchworks (2009) (43)
Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies (2018) (42)
Fake news portrayals of stem cells and stem cell research. (2017) (42)
Harm, hype and evidence: ELSI research and policy guidance (2013) (42)
Health Misinformation and the Power of Narrative Messaging in the Public Sphere (2019) (41)
Stem cell tourism and public education: the missing elements. (2014) (39)
Why a Criminal Ban? Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate (2007) (37)
Providing Genetic Testing Through the Private Sector: A View From Canada (2001) (37)
Genetic testing, ethical concerns, and the role of patent law (2000) (36)
Technology assessment and resource allocation for predictive genetic testing: A study of the perspectives of Canadian genetic health care providers (2009) (35)
Willingness to Pay for Genetic Testing: A Study of Attitudes in a Canadian Population (2009) (35)
Human Dignity as a Criterion for Science Policy (2005) (35)
Representations of the health value of vitamin D supplementation in newspapers: media content analysis (2014) (34)
Newspaper reporting on legislative and policy interventions to address obesity: United States, Canada, and the United Kingdom (2011) (33)
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. (2010) (33)
How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments (2019) (33)
Addressing Internalized Weight Bias and Changing Damaged Social Identities for People Living With Obesity (2019) (33)
From genomic medicine to precision medicine: highlights of 2015 (2016) (33)
Societal Values in the Allocation of Healthcare Resources (2011) (32)
Stem cell tourism and Canadian family physicians. (2012) (32)
Stem Cell Research and Economic Promises (2010) (32)
Direct-to-consumer testing: if consumers are not anxious, why are policymakers? (2011) (31)
Representing a “revolution”: how the popular press has portrayed personalized medicine (2018) (30)
Direct-To-Consumer Genetics and Health Policy: A Worst-Case Scenario? (2009) (30)
Athletes' use of unproven stem cell therapies: adding to inappropriate media hype? (2012) (30)
The Evolution of Policy Issues in Stem Cell Research: An International Survey (2012) (30)
The commercialization of genetic research : ethical, legal, and policy issues (1999) (29)
Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals (2008) (29)
Canadian Newspaper Coverage of the A/H1N1 Vaccine Program (2011) (29)
Guidance for considering ethical, legal, and social issues in health technology assessment: Application to genetic screening (2008) (29)
Informed consent in embryonic stem cell research: Are we following basic principles? (2007) (28)
Professional Regulation: A Potentially Valuable Tool in Responding to “Stem Cell Tourism” (2014) (28)
Representations of Stem Cell Clinics on Twitter (2014) (28)
Law and policy in the era of reproductive genetics (2004) (27)
Selling falsehoods? A cross-sectional study of Canadian naturopathy, homeopathy, chiropractic and acupuncture clinic website claims relating to allergy and asthma (2016) (26)
Spinning the Genome: Why Science Hype Matters (2019) (26)
What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism” (2013) (25)
The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions (2015) (25)
Commercialization, patenting and genomics: researcher perspectives (2009) (25)
Gene patents and the standard of care. (2002) (25)
COVID-19 and ‘immune boosting’ on the internet: a content analysis of Google search results (2020) (25)
A critical analysis of obesity prevention policies and strategies (2017) (24)
Public health law and policy in Canada (2008) (24)
Financial incentives to increase Canadian organ donation: quick fix or fallacy? (2014) (24)
Eugenic Policies in Alberta: From the Systematic to the Systemic (1996) (24)
Patents, commercialization and the Canadian stem cell research community. (2008) (24)
Genome Medicine: past, present and future (2011) (24)
Human cloning laws, human dignity and the poverty of the policy making dialogue (2003) (22)
The Commercialization of Human Genetics: A Discussion of Issues Relevant to the Canadian Consumer (1998) (21)
“Immune Boosting” in the time of COVID: selling immunity on Instagram (2020) (21)
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial (2019) (21)
Medicine. The future of personal genomics. (2007) (21)
Stem cell research policy and iPS cells (2009) (21)
Evaluating the “family veto” of consent for organ donation (2016) (21)
Human gene editing: revisiting Canadian policy (2017) (20)
Marginally scientific? Genetic testing of children and adolescents for lifestyle and health promotion (2015) (20)
Research ethics and stem cells (2015) (19)
Challenging a Well Established Consent Norm?: One Time Consent for Biobank Research (2007) (19)
Let’s do better: public representations of COVID-19 science (2021) (19)
Does Debunking Work? Correcting COVID-19 Misinformation on Social Media (2020) (19)
Variations and voids: the regulation of human cloning around the world (2004) (19)
Stem cell research ethics: consensus statement on emerging issues. (2007) (18)
Wishful thinking: defining "medically necessary" in Canada. (1996) (18)
Gene testing in the biotech century: are physicians ready? (1999) (18)
From human genes to stem cells: new challenges for patent law? (2003) (18)
“Neurohype” and the Name Game: Who's to Blame? (2010) (18)
CRISPR in the North American popular press (2019) (18)
The Fountain of Stem Cell-Based Youth? Online Portrayals of Anti-Aging Stem Cell Technologies. (2015) (18)
Variation in Ethics Review of Multi-Site Research Initiatives (2011) (17)
Media portrayal of non-invasive prenatal testing: a missing ethical dimension (2016) (17)
Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers (2016) (17)
Gordie Howe’s “Miraculous Treatment”: Case Study of Twitter Users’ Reactions to a Sport Celebrity’s Stem Cell Treatment (2016) (16)
Non-refundable tax credits are an inequitable policy instrument for promoting physical activity among Canadian children. (2012) (16)
Media portrayal of illness-related medical crowdfunding: A content analysis of newspaper articles in the United States and Canada (2019) (16)
Microsystems and Nanoscience for Biomedical Applications: A View to the Future (2004) (16)
Ethics Hype? (2016) (16)
Public Perceptions and Biobanking: What Does the Research Really Say? (2012) (15)
Gordie Howe’s Stem Cell ‘Miracle’: A Qualitative Analysis of News Coverage and Readers’ Comments in Newspapers and Sports Websites (2015) (15)
Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research. (2003) (15)
The stem cell market and policy options: a call for clarity (2018) (14)
Clones, controversy, and criminal law: a comment on the proposal for legislation governing assisted human reproduction. (1969) (14)
The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology (2002) (14)
Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers (2013) (14)
Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information. (2002) (14)
Canada: Public Health Genomics (2008) (14)
Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: integrating science, legal duties and ethical mandates. (1997) (14)
Potions, promises and paradoxes: complementary medicine and alternative medicine and malpractice law in Canada. (2001) (13)
Defining ‘medical necessity’ in an age of personalised medicine: A view from Canada (2014) (13)
Looking back at genomic medicine in 2011 (2012) (13)
Injecting doubt: responding to the naturopathic anti-vaccination rhetoric (2017) (13)
International stem cell environments: a world of difference (2009) (13)
Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. (2017) (13)
Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment. (2005) (13)
SafetyNET: An interdisciplinary research program to support a safety culture for spinal manipulation therapy (2014) (13)
Policy Conflicts: Gene Patents and Health Care in Canada (2005) (13)
Crowdfunding Cannabidiol (CBD) for Cancer: Hype and Misinformation on GoFundMe. (2020) (13)
Biomedical Research and the Commercialization Agenda: A Review of main Considerations for Neuroscience (2008) (13)
Supported by science?: what canadian naturopaths advertise to the public (2011) (12)
Media Representations of Genetic Discoveries: Hype in the Headlines? (2014) (12)
Balancing Efficiency and the Protection of Research Participants: Canadian Allergy/Asthma Researchers' Perspectives on the Ethics Review of Multi-Site Health Research (2011) (12)
Physician liability and non-invasive prenatal testing. (2014) (12)
Human genetic research, race, ethnicity and the labeling of populations: recommendations based on an interdisciplinary workshop in Japan (2014) (12)
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions (2014) (12)
Science Spin: iPS Cell Research in the News (2011) (12)
Tissue banking, patient rights, and confidentiality: tensions in law and policy. (2004) (12)
Chiropractic and Spinal Manipulation Therapy on Twitter: Case Study Examining the Presence of Critiques and Debates (2016) (12)
Quality of life drives patients’ preferences for secondary findings from genomic sequencing (2020) (11)
Stem cell research, scientific freedom and the commodification concern (2012) (11)
Popular Representations of Race: The News Coverage of BiDil (2008) (11)
Creating needs? A review of survey data and concerns relevant to the commercialization of genetic testing. (2001) (11)
The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care (2021) (11)
A critical analysis of obesity prevention policies and strategies. (2017) (11)
Tracing the use and source of racial terminology in representations of genetic research (2011) (11)
Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis "wonder drug". (2016) (11)
Industry involvement in publicly funded biobanks (2014) (11)
DNA databanks, public opinion and the law. (2002) (11)
The face of chiropractic: evidence-based? (2015) (10)
Stem Cell Patents and Social Controversy: A Speculative View from Canada (2006) (10)
Stem cell tourism (2012) (10)
Predictive or preposterous? The marketing of DTC genetic testing (2011) (10)
Media portrayal of herbal remedies versus pharmaceutical clinical trials: impacts on decision. (2007) (10)
Patients' crowdfunding campaigns for alternative cancer treatments. (2019) (10)
Commercialization and stem cell research: a review of emerging issues. (2013) (10)
Trends in Evidence-Based Medicine for Herbal Remedies and Media Coverage (2006) (10)
Legal Foundations for a National Public Health Agency in Canada (2005) (10)
The challenge of regulating rapidly changing science: stem cell legislation in Canada. (2009) (10)
Incentives and organ donation: what’s (really) legal in Canada? (2014) (10)
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action (2019) (9)
Newspaper coverage of biobanks (2014) (9)
Crowdfunding for complementary and alternative medicine: What are cancer patients seeking? (2020) (9)
Mapping The Coverage Of Neuroimaging Research (2010) (9)
Deterministic?: Newspaper Representations of Obesity and Genetics (2009) (9)
The informed gatekeeper?: a commentary on genetic tests, marketing pressure and the role of primary care physicians. (2001) (9)
Position statement on the provision and procurement of human eggs for stem cell research. (2013) (9)
Bill C-13 The Assisted Human Reproduction Act: examining the arguments against a regulatory approach. (2002) (9)
Nutrigenomics patents and commercialization: old wine in a new bottle? (2009) (8)
The consumer representation of DNA ancestry testing on YouTube (2020) (8)
Whistling in the Wind (2000) (8)
The “subluxation” issue: an analysis of chiropractic clinic websites (2019) (8)
First Pharmacogenomics, Next Nutrigenomics: Genohype or Genohealthy? (2006) (8)
Scientific freedom and research cloning: can a ban be justified? (2004) (8)
The commercialization of human genetics: profits and problems. (1998) (8)
The Law and Ethics of Switching from Biologic to Biosimilar in Canada (2020) (8)
EXPERT PANEL ON THE FUTURE OF FOOD BIOTECHNOLOGY (2001) (8)
Gene patents, health care policy and licensing schemes. (2006) (8)
Ethics Watch: Gene banks and blanket consent (2002) (8)
Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process (2017) (8)
Xenotransplantation and public health: identifying the legal issues. (1999) (8)
Conflicts of interest in clinical research: addressing the issue of physician remuneration. (2002) (7)
Current opinions in organ allocation (2018) (7)
Navigating physicians' ethical and legal duties to patients seeking unproven interventions abroad. (2015) (7)
Food Allergy Policy and the Popular Press Perspectives From Canadian Newspapers (2011) (7)
COVID-19 and Vitamin D Misinformation on YouTube: Content Analysis (2021) (7)
Family veto in organ donation in Canada: framing within English-language newspaper articles. (2017) (7)
Genetic testing, legal capacity and adolescents. (1998) (7)
Open science precision medicine in Canada: Points to consider (2019) (7)
2012 highlights in translational 'omics (2013) (7)
The gene patent controversy on Twitter: a case study of Twitter users’ responses to the CHEO lawsuit against Long QT gene patents (2015) (6)
Creating Needs? (2001) (6)
Regulating the genetic revolution. (1999) (6)
Cloning and genetic determinism—a call for consistency (2001) (6)
Human Gene Patents: Proof of Problems (2008) (6)
Obesity Genes, Personalized Medicine, and Public Health Policy (2015) (6)
The law, adolescents, and the APOE epsilon 4 genotype: a view from Canada. (1999) (6)
Harmonizing Commercialisation and Gene Patent Policy with Other Social Goals (2003) (6)
From Human Embryos to Interspecies Creations: Ethical and Legal Uncertainties Surrounding the Creation of Cytoplasmic Hybrids for Research (2008) (6)
‘Gut health’ and the microbiome in the popular press: a content analysis (2021) (6)
Genetic Research Tools, the Research Exception and Open Science (2005) (6)
From Kim Kardashian to Dr. Oz: The Future Relevance of Popular Culture to Our Health and Health Policy (2016) (6)
Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel (2018) (6)
A novel serine-specific kinase activity associated with exocrine secretory granules. (1995) (6)
The Hydroxychloroquine Twitter War: A case study examining polarization in science communication (2021) (6)
Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation. (2012) (5)
Nutrigenomics and the Promise of Prevention: Representations and Realities (2014) (5)
Legal liability and research ethics boards: the case of neuroimaging and incidental findings. (2012) (5)
DTC genetic testing: pendulum swings and policy paradoxes (2012) (5)
The Regulation of Embryonic Stem Cell Research : A Few Observations on the International Scene (2003) (5)
Winnipeg Child and Family Services v. D.F.G.: a commentary on the law, reproductive autonomy and the allure of technopolicy. (1969) (5)
Biotechnology and Science in Video Games: A Destructive Portrayal? (2011) (5)
The right to control and access genetic research information: Does McInerney offer a way out of the consent/withdrawal conundrum? (2014) (5)
Pragmatic clinical trials and the consent process (2018) (5)
Minimal Risk and Large-scale Biobank and Cohort Research (2009) (5)
Commentary: the law, unproven CAM and the two-hats fallacy (2012) (5)
Popular Culture Representations of Science: Views from the Canadian Stem Cell Research Community (2010) (5)
The commercialization of genomic research in Canada. (2010) (5)
The law of food allergy and accommodation in Canadian schools (2018) (5)
Currents in Contemporary Ethics (2004) (5)
Policy Uncertainty, Sequencing, and Cell Lines (2013) (5)
Commenting on chiropractic: A YouTube analysis (2017) (5)
Media portrayal of conflicts of interest in herbal remedy clinical trials. (2006) (5)
Obesity, legal duties, and the family physician. (2007) (5)
Crowdfunding Campaigns and COVID-19 Misinformation. (2021) (5)
Regulating NRGTs (new reproductive and genetic technologies): is criminalization the solution for Canada? (1997) (5)
Science powers commerce: Mapping the language, justifications, and perceptions of the drive to commercialize in the context of Canadian research (2015) (5)
Politics, prohibitions and the lost public perspective: a comment on Bill C-56: the Assisted Human Reproduction Act. (1969) (5)
The allocation of genetic services: economics, expectations, ethics and the law. (1995) (5)
Reflections on the gene patent war: the myriad battle, Sputnik and beyond. (2011) (5)
The Law, Adolescents, and the APOE ε4 Genotype: A View from Canada (1999) (5)
Human dignity and biotechnology policy (2009) (4)
Erratum: Personal medicine—the new banking crisis (2012) (4)
Portrayal of umbilical cord blood research in the North American popular press: promise or hype? (2020) (4)
Whistling in the wind: patents on genetic research are a reality. It's time to reframe the debate. (2000) (4)
Emerging Health Technologies (2008) (4)
The Commercialization of Genetic Research (2012) (4)
Regulating the Commercialization of Human Genetics (1999) (4)
Liability in the Genetic Era: Wrongful Birth and Wrongful Life Lawsuits (2001) (4)
Privacy in Direct-to-Consumer Genetic Testing. (2019) (4)
Policy Challenges for Organ Allocation in an Era of “Precision Medicine” (2020) (4)
How Do Current Common Law Principles Impede or Facilitate Change (2002) (4)
An investigation of embryo donation, informed consent, and research oversight in Canadian human embryonic stem cell research. (2007) (4)
The law and problematic marketing by private umbilical cord blood banks (2020) (4)
The regulation of science and the Charter of Rights: would a ban on non-reproductive human cloning unjustifiably violate freedom of expression? (2004) (4)
Xenotransplantation: Consent, Public Health and Charter Issues* (2001) (4)
Research, Digital Health Information and Promises of Privacy: Revisiting the Issue of Consent (2020) (3)
Stem Cell Research in the News: More than a Moral Status Debate? (2014) (3)
Health Care Reform: Can Tort Law Meet the Challenge (1994) (3)
Elle Macpherson, “anti-vaxx” nonsense, and the opportunity to engage (2018) (3)
Peddling promise? An analysis of private umbilical cord blood banking company websites in Canada (2021) (3)
Potions , Promises and Paradoxes : Complementary and Alternative Medicine and Malpractice Law in Canada (2003) (3)
Patents or Commercialisation Pressure? A (Speculative) Search for the Right Target (2012) (3)
A shifting concept of family? (2002) (3)
Newspaper portrayals of spinal manipulation therapy: Canada, United States, and the United Kingdom (2013) (3)
Using Data From a Short Video Social Media Platform to Identify Emergent Monkeypox Conspiracy Theories (2022) (3)
Non-refundable Tax Credits Are an Inequitable Policy Instrument for Promoting Physical Activity Among Canadian Children (2012) (3)
Influenza vaccination discourse in major Canadian news media, 2017–2018 (2018) (3)
Physicians' liability and drug formulary restrictions. (2002) (3)
Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues. (2005) (3)
Research Ethics Challenges in Neuroimaging Research: A Canadian Perspective (2012) (3)
Legal regulation of cancer surveillance: Canadian and international perspectives. (2000) (2)
Informed Consent and Patient Comprehension: The Law and the Evidence (2013) (2)
Discussing The Anatomy Table and The Vaccination Picture (2020) (2)
Curbing transplant tourism: Canadian physicians and the law (2016) (2)
Politics and Paradoxes: Chaoulli and the Alberta Reaction (2005) (2)
Policy Paradoxes: The Commercialization of Stem Cell Research (2012) (2)
Direct‐to‐consumer genetic testing — where should we focus the policy debate? (2013) (2)
A taxonomy of risk‐associated alternative health practices: A Delphi study (2021) (2)
Analyzing natural herd immunity media discourse in the United Kingdom and the United States (2022) (2)
Discussing non‐invasive prenatal testing on Reddit: The benefits, the concerns, and the comradery (2020) (2)
Diversifying stem cell debates: Including Muslim contexts and perspectives (2022) (2)
Should we call it fraud? (2012) (2)
Discussing NIPT on Reddit: The benefits, the concerns, the comradery. (2020) (2)
Promotion of Testing for Celiac Disease and the Gluten-Free Diet Among Complementary and Alternative Medicine Practitioners (2019) (2)
Research ethics and the role of the professional bodies: a view from Canada. (2004) (2)
Genetics services and market forces (2002) (2)
Public Solicitation and The Canadian Media: Two Cases of Living Liver Donation, Two Different Stories (2019) (2)
Reconsenting paediatric research participants for use of identifying data (2022) (2)
Commercialization versus open science: Making sense of the message(s) in the bottle (2012) (2)
Introduction: genetic diversity and science communication (2006) (2)
Somatic cell nuclear transfer—how science outpaces the law (2003) (2)
Ethics Watch: Public perceptions and regulatory policy (2002) (2)
Genetic Testing, Liability, and Regulatory Policy: The Canadian Situation (2001) (2)
Nutrigenomics, Popular Representations and the Reification of "Race"? (2008) (2)
Doing Research with Vulnerable Populations: The Case of Intravenous Drug Users (2018) (2)
Medical injuries and malpractice: is it time for "no fault"? (1993) (2)
BiDil, Clinical Trials and the Popular Press: An Exploration of Newspaper Coverage (2008) (2)
The Cure For Everything (2012) (1)
The practice of human genetics: emerging areas of consensus? (1995) (1)
Practically confidential. Legal and ethical dilemmas in practice. (1995) (1)
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions (2014) (1)
Cancer patient perceptions on the ethical and legal issues related to biobanking (2013) (1)
Public Representations Of Neurogenetics (2011) (1)
The challenge of human challenge research models: A Canadian perspective (2017) (1)
Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance? (2009) (1)
Genetics, 'family consent' and the law (2002) (1)
3. Medical Malpractice, the Common Law, and Health-Care Reform (2004) (1)
Human Gene Patents and Genetic Testing (2010) (1)
Introduction: Infectious Diseases Forum (1969) (1)
Looking back at genomic medicine in 2011 (2012) (1)
Book Reviews-Legal Rights and Human Genetic Material (1998) (1)
Author ' s response to reviews Title : Cancer Patient Perceptions on Biobanking Research (2013) (1)
Human cloning a decade after Dolly (2007) (1)
Nanotechnology: Facts and Fictions (2004) (1)
Harm, hype and evidence: ELSI research and policy guidance (2013) (1)
Covid-19 and “Immune Boosting” on the Internet: A Content Analysis of Google Search Results (2020) (1)
It’s not all in the genes (2014) (1)
Comment: Bill 11,Health Care Protection Act (2000) (1)
ter Neuzen v. Korn and The Standard of Care: A Call for Caution (1996) (1)
Living Organ Donation : Consent Challenges (2007) (1)
Genetic Testing: Perceptions, Problems, and Policy Responses (2012) (1)
Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer (2009) (1)
Legal aspects of the physician-patient relationship. Considerations during health care reform in Canada. (1997) (1)
Gene Patents, Human Clones, and Biotechnology Policy: The Challenges Created by Globalization (1969) (1)
REGULATING THE GENETIC REVOLUTION: WHAT IS AND ISN’T HAPPENING IN CANADA (1992) (1)
Commentary: An examination of the public justifications for the expansion of Canadian naturopaths' scope of practice. (2011) (1)
Framing Nutrigenomics for Individual and Public Health: Public Representations of an Emerging Field (2009) (1)
Stem cell research , scientific freedom and the commodification concern Vague concerns about possible commodification should not serve as justification to limit the freedom of research (2013) (1)
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial (2019) (0)
Response—Regulating Genetic Tests: Who Owns the Data? (2010) (0)
Test Samples and Laboratory Protocols (2006) (0)
Immune Boosting in the Time of COVID: Selling Immunity on Instagram (2020) (0)
Quality of life drives patients’ preferences for secondary findings from genomic sequencing (2020) (0)
Author ' s response to reviews Title : Technology assessment and resource allocation for predictive genetic testing : A pilot study of the perspectives of Canadian genetic health care providers (2008) (0)
High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation (2021) (0)
Advertising Alternative Cancer Treatments and Approaches on Meta Social Media Platforms (Preprint) (2022) (0)
Models for Bioethics Research (2014) (0)
16. The Media, Marketing, and Genetic Services (2006) (0)
Gordie Howe’s Stem Cell ‘Miracle’: A Qualitative Analysis of News Coverage and Readers’ Comments in Newspapers and Sports Websites (2015) (0)
Authors' response to Invited Commentary by Brady and Beausoleil. (2017) (0)
The �subluxation� issue: An analysis of chiropractic clinic websites (Preprint) (2018) (0)
A Rejoinder to Professor Anand (1969) (0)
Newspaper Coverage of COVID-19 Vaccination Requirement for Organ Transplant (2022) (0)
2012 highlights in translational 'omics (2013) (0)
Defining "Race" as the Defining Problem (2009) (0)
Health Law Issues in Canada Today: Emerging Genetic Policies (1999) (0)
Representations of Stem Cell Clinics on Twitter (2014) (0)
Open science versus commercialization: a modern research conflict? (2012) (0)
Privacy Considerations in the Canadian Regulation of Commercially-Operated Healthcare Artificial Intelligence (2022) (0)
Introduction: The Age of Personal Genomics (2010) (0)
The law and problematic marketing by private umbilical cord blood banks (2020) (0)
Paternity testing in the genetic era. (1996) (0)
Biobanking and the consent problem (2019) (0)
CRISPR in the North American popular press (2019) (0)
COVID-19 and Vitamin D Misinformation on YouTube: A Content Analysis (Preprint) (2021) (0)
From genomic medicine to precision medicine: highlights of 2015 (2016) (0)
Personalized Medicine: Altering the Role of Medical Necessity in Health System Policy (2014) (0)
Xenotransplantation and Public Health: Identifying the Legal Issues (1999) (0)
claims relating to allergy and asthma chiropractic and acupuncture clinic website of Canadian naturopathy , homeopathy , Selling falsehoods ? A cross-sectional study (2016) (0)
Great expectations: patients’ preferences for clinically significant results from genomic sequencing (2023) (0)
Cell Stem Cell ISSCR : Committee Forum Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research (2013) (0)
Reviewer Acknowledgment (2009) (0)
Representing a “revolution”: how the popular press has portrayed personalized medicine (2018) (0)
Biotechnology Patents and Embryonic Stem Cell Research: Emerging Issues (Part I) (2004) (0)
Compelled Disclosure of Confidential Information in Patient Safety Research. (2016) (0)
Media coverage of Obesity-Related Legislative and Policy Interventions (2011) (0)
Integrating Bioethics and Health Law Into the Canadian Institutes of Health Research (1999) (0)
Genetics and market forces. (2002) (0)
Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers (2013) (0)
Erratum: Around the world in a month (2012) (0)
Law and Ethics in Biomedical Research: Regulation, Conflict of Interest, and Liability (2007) (0)
The gene patent controversy on Twitter: a case study of Twitter users’ responses to the CHEO lawsuit against Long QT gene patents (2015) (0)
Authors’ response to Invited Commentary by Brady and Beausoleil (2017) (0)
Public Trust and Regulatory Governance as represented through the Media (2014) (0)
As new media proliferate and the public's trust and engagement in science are influenced by industry involvement in academic research, an interdisciplinary workshop provides some recommendations to enhance science communication. (2009) (0)
A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals (2008) (0)
Human gene editing: revisiting Canadian policy (2017) (0)
Globalization and biotechnology policy (2006) (0)
Non-Invasive Prenatal Screening: Navigating the Relevant Legal Norms. (2020) (0)
Commentary: the law, unproven CAM and the referral challenge (2013) (0)
Author ' s response to reviews Title : Technology assessment and resource allocation for predictive genetic testing : A study of the perspectives of Canadian genetic health care providers (2009) (0)
The Evolution of Policy Issues in Stem Cell Research: An International Survey (2012) (0)
Comparing direct-to-consumer genetic testing services in English, Japanese, and Chinese websites (2023) (0)
Legal foundations for a national public health agency in Canada. Commentary (2005) (0)
Stem cells, politics and the progress paradigm. (2006) (0)
Semi-Structured Interview Instrument for Canadian Genetic Health Care Providers (2016) (0)
Restricting marketing to children: Consensus on policy interventions to address obesity (2013) (0)
Symposium on Bill C-13: The Assisted Human Reproduction Act (2002) (0)
At the Institute (1975) (0)
Development of patient “profiles” to tailor counseling for incidental genomic sequencing results (2019) (0)
Against hyperbole, distortion, and overselling (2016) (0)
Many Thanks to Bioethics Reviewers. (2015) (0)
Donation and transplantation coverage in the Canadian media: a content analysis of story focus over 2 decades (2022) (0)
Commercialization of Human Genetic Research (2006) (0)
Representations of the health value of vitamin D supplementation in newspapers and magazines: Media content analysis (2014) (0)
Currents in Contemporary Ethics (2002) (0)
Genetic Research and Representations of Race (2015) (0)
Science Powers Commerce’: Language, Justification and Perceptions of the Drive to Commercialize Canadian Research (2015) (0)
Around the world in a month (2020) (0)
HEALTH CARE REFORM: CAN TORT LAW MEET THE CHALLENGE? 1 (2017) (0)
Contents Vol. 8, 2005 (2005) (0)
How Can the Public Distinguish Between Fact and Fiction (2017) (0)
Is Personal Genomics The Answer (2013) (0)
That Personal Touch (2011) (0)
Reply to Ian Dunham (1998) (0)
COVID-19 lockdown revisionism (2023) (0)
Glenn McGee , The Perfect Baby: A Pragmatic Approach to Genetics . Reviewed by (1997) (0)
The commercialization of university-based research: Balancing risks and benefits (2015) (0)
Media Portrayal of Conflicts of Interest in Biomedical Research (2014) (0)
Human genetic research, race, ethnicity and the labeling of populations: recommendations based on an interdisciplinary workshop in Japan (2014) (0)
Book Review: Future Bioethics: Overcoming Taboos, Myths, and Dogma, by Ronald A. Lindsay. New York: Prometheus Books, 2008. 313 pp (2009) (0)
Subject Index Vol. 8, 2005 (2005) (0)

This paper list is powered by the following services:

Other Resources About Timothy Caulfield

en.wikipedia.org

What Schools Are Affiliated With Timothy Caulfield?

Timothy Caulfield is affiliated with the following schools:

University of Alberta

Image Attributions

Image Source for Timothy Caulfield